R COMPANY PERSPECTIVE 55
Figure 1: The advantages of automation
Lubrizol’s technical team analyses in vitro and in vivo data to validate conclusions, using biomolecular expertise, computer vision, and proprietary web apps to evaluate ingredient performance for skin benefits. Specialized algorithms process data and extract significant information from clinical testing images and videos. Lubrizol scientists are also enhancing new product development with high- throughput screening tools. “These laboratories are crucial to our
operations as they approach the pivotal phase where years of in vitro research, consisting of numerous screening and functional validation assays, are tested on volunteers,” said Raquel Delgado, Lubrizol’s Sr Director, Lubrizol Life Science Technology. “Consistency in these laboratories is of the utmost importance. We ensure that our facilities, equipment, and trained personnel are utilized to their full potential. This enables us to gain insights into our ingredients across various skin types and conditions globally. “Additionally, we will soon be expanding our
operations in Brazil, which will also allow us to extend our research into hair care, leveraging the diversity offered by the country.”
The digital way ahead From molecular design to screening and formulation expertise, Lubrizol’s research programs now incorporate advanced capabilities across all stages. Human insight is still critical, says Delgado. “By integrating the profiles of new scientists
with traditional life science disciplines (chemists, pharmacists, biologists), we have enhanced our ability to compete and provide superior
Figure 2: Lubrizol Beauty Research Institute in Shanghai
ingredients by combining human insight with cutting-edge artificial intelligence tools.” While digital tools play a large role in R&D,
data gained through market intelligence is increasingly valuable for Lubrizol’s customers and has a big impact on ingredient development.
Consumer insights + market trends + scientific expertise = innovation for customers Lubrizol’s Foresee Lab™ monitors market trends and consumer behaviours, then translates the findings into insights and innovation opportunities for brands. The work is backed by high-end digital platforms and experts globally. “We identified a unique opportunity:
combining consumer insights and market trends with our scientific expertise to help B2B beauty
customers turn insights into innovations that really resonate with final consumers. This approach allowed us to go beyond technical support and demonstrate a deep understanding of the market from both a consumer and trend perspective—key to building stronger customer relationships in the beauty industry,” says Paola Perez, a Global Strategic Marketing Manager for Beauty at Lubrizol. “Once we found this sweet spot, we spent
two years expanding our ecosystem of data sources. We integrated more digital platforms powered by AI to track what consumers are discussing online, what they’re searching for, and to forecast the growth of skin care technologies and claims. This enabled us to deliver even more relevant, forward-looking insights to our customers. Also, the team has a background in innovation, sociology, marketing and science, with wide experience in the B2C space launching new products and brands,” Perez said.
Foresee Lab success story: Facial proportions restorer serum product concept Lubrizol’s Foresee Lab team recently delved into research that revealed growing interest in facial asymmetry surgery and face sculpting. Beyond traditional lifting and filling, consumers are increasingly concerned about facial shape and symmetry, as they are seen as strong as strong indicators of age, intensified by frequent screen use.
C
N
E
I
L
E
A
B
T
G
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114
